Medmira - Crunchbase Company Profile & Funding

Q: Where is Medmira's headquarters?

Medmira is located in Halifax, Nova Scotia, Canada.

Q: When was the last funding round for Medmira?

Medmira closed its last funding round on obfuscated from a Post-IPO Equity round.

Overview

Medmira

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Medmira

CB Rank

199907

MedMira is dedicated to improving human health by providing the best in rapid diagnostics.

Founded

obfuscation

Public

Post-IPO Equity

Halifax, Nova Scotia, Canada

11-50

medmira.com/

Health Care

Health Diagnostics

Information Technology

Manufacturing

Medical

Medical Device

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Key People

Hermes Chan: Co-Founder & CEO
Nicole Crenshaw: VP of Commercial Operations

Details

Legal Name

MedMira Inc.

Operating Status

Active

Stock Symbol

CVE:MIR

Company Type

For Profit

Founders

Hermes Chan

About the Company

MedMira is dedicated to improving human health by providing the best in rapid diagnostics. They bring together the right balance of R&D, best business practices and quality manufacturing to deliver advanced rapid diagnostics and technology. Their rapid tests are critical in delivering solutions for today’s greatest healthcare challenges.

Phone Number

9024501580

Contact Email

info@medmira.com

Predictions & Insights

Growth Insight

See this Growth Insight

Medmira is

Lorem

to be growing

Top Contributing Factors

Financial Decline

Products & Services

Reveal G4

FDA-approved test for instant HIV results using Rapid Vertical Flow Technology.

Multiplo Multiplex Tests

Tests for simultaneous detection of HIV-1/2, Hepatitis B and C, and Syphilis.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Medmira	—	obfuscated obfuscation	—	Post-IPO Equity